RPL22 and hematologic disorder: These and other observations underscore the critical role that alterations in lipid metabolism play in solid and hematologic malignancies, as well as in the control of HSC function.47–49,80,108 Nevertheless, the molecular basis by which enhanced FAO supports the function of normal HSCs and leukemia cells generally, and specifically in the context of Rpl22 loss, remains to be established.